Bio Group AG已申请美国首次公开募股（IPO），以帮助资助其抗体药物的临床试验，用于治疗严重呼吸系统和皮肤疾病。
Bio Group AG filed for a US initial public offering to help fund trials of its antibody drugs to treat serious respiratory and skin diseases.
根据周五向美国证券交易委员会提交的文件，Windward成立于2024年，总部位于瑞士巴塞尔，拥有一种单克隆抗体处于晚期临床试验阶段，用于治疗严重哮喘和慢性阻塞性肺病，还有一种双特异性抗体处于早期临床试验阶段，用于治疗包括湿疹在内的炎症性疾病。
Founded in 2024, Basel, Switzerland-based Windward has a monoclonal antibody in advanced trials to treat severe asthma and chronic obstructive pulmonary disease, and a bispecific antibody in early-stage trials to treat inflammatory diseases including eczema, according to a filing Friday with the US Securities and Exchange Commission.
文件显示，该公司最大投资者之一是总部位于丹麦的Novo Holdings A/S，即管理诺和诺德基金会资产的控股公司。截至2026年6月30日的六个月内，Windward净亏损4260万美元，无营收，而上年同期净亏损2280万美元，同样无营收。
The company, which counts Denmark-based Novo Holdings A/S, the holding company that manages the assets of the Novo Nordisk Foundation, among its biggest investors, had a net loss of $42.6 million on no revenue for the six months ended June 30, 2026, versus a net loss of $22.8 million on no revenue for the corresponding period a year before, the filing shows.
Windward由首席执行官Luca Santarelli领导，他曾是专注于胃肠道疾病的VectivBio Holding AG的首席执行官兼创始人，该公司于2023年以10亿美元被Ironwood Pharmaceuticals Inc.收购。
Windward is led by Chief Executive Officer Luca Santarelli, the former CEO and founder of gastrointestinal disease-focused VectivBio Holding AG prior to its $1 billion acquisition by Ironwood Pharmaceuticals Inc. in 2023.
除了Novo，Windward的最大投资者还包括OrbiMed Advisors、Santarelli、SR One Capital Management、Omega Fund Management、RTW Investments以及Blue Owl Capital管理的基金。
Along with Novo, Windward’s biggest investors include OrbiMed Advisors, Santarelli, SR One Capital Management, Omega Fund Management, RTW Investments and funds managed by Blue Owl Capital.
据当时的一份声明，今年5月，Windward在OrbiMed领投的一轮扩大规模的跨界融资中筹集了1.65亿美元，Novo和Omega等投资者参投。声明显示，该公司累计通过股权融资筹集了3.65亿美元。
In May, Windward raised $165 million in an upsized crossover financing led by OrbiMed, with participation from investors including Novo and Omega, according to a statement at the time. The company has raised $365 million in equity, the statement showed.
根据文件，Windward的IPO由Jefferies Financial Group Inc.、Toronto-Dominion Bank、Piper Sandler Cos.和UBS Group AG牵头承销。公司预计其股票将在纳斯达克全球市场交易，代码为WWB。
Windward’s IPO is being led by Jefferies Financial Group Inc., Toronto-Dominion Bank, Piper Sandler Cos. and UBS Group AG, according to the filing. The company expects its shares to trade on the Nasdaq Global Market under the symbol WWB.